Status:
ENROLLING_BY_INVITATION
Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer
Lead Sponsor:
Yanhong Deng
Conditions:
Rectal Cancer
Lymph Node Metastasis
Eligibility:
All Genders
18-65 years
Brief Summary
We evaluated all related clinical and pathologic data of patients with Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy, including the pathologic regression grading in the primar...
Detailed Description
This large-scale, multi-center cohort study investigates the clinical significance of Pathologic Regression in lymph nodes (LNs) of patients with Locally Advanced Rectal Cancer (LARC) following Neoadj...
Eligibility Criteria
Inclusion
- \- Adults (≥18 years) diagnosed with locally advanced rectal adenocarcinoma (clinical stage II-III).
- Completion of NCRT followed by curative-intent surgery. Availability of pre- and post-treatment histopathologic data, including standardized regression grading and digitized whole-slide images (WSIs).
Exclusion
- \- distant Metastatic disease at diagnosis. Incomplete clinical or pathologic records.
Key Trial Info
Start Date :
January 30 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 25 2026
Estimated Enrollment :
1080 Patients enrolled
Trial Details
Trial ID
NCT06883084
Start Date
January 30 2014
End Date
February 25 2026
Last Update
March 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.